Liver carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
This meta-analysis revealed that HSP27 may play a key role in the development of HCC and could be a reliable biomarker for the prognosis of patients with HCC.
|
29563808 |
2018 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Previous study indicated that Hsp27 might be an important biomarker in hepatocellular carcinoma (HCC).
|
28903396 |
2017 |
Liver carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Hsp27 was upregulated in HCC tissues, and Hsp27 overexpression significantly facilitated formation of HCC cell colony and invasion in normoxia and tolerance in hypoxia by interacting with HIF-1α.
|
26381739 |
2015 |
Liver carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma cells to 17-allylamino-17-demethoxygeldanamycin.
|
23469976 |
2013 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
These identified proteins, which include stratifin (14-3-3), transgelin 2, heat-shock protein (HSP)70, HSP27, manganese superoxide dismutase, prohibitin, DJ1, α-enolase, peroxiredoxin 6, aldo-keto reductase family member B10, phosphoglycerate kinase 1, α-1-antitrypsin and nm23-H1, may play a role in the development of HCC.
|
21472284 |
2012 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We also demonstrated that Hsp27 inhibits cisplatin- induced HCC cell death through autophagy activation.
|
21888831 |
2011 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Heat shock protein 27(HSP27) is confirmed as an apoptosis regulator, but its antiapoptotic mechanism in metastatic hepatocellular carcinoma (HCC) cells remains unclear.
|
19331697 |
2009 |
Liver carcinoma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Taken together, this study reveals the important role of this PKC beta-ERK(1/2)/p38MAPK-HSP27 pathway, which was verified for the first time, in modulating HCC cell motility and invasion.
|
18167130 |
2008 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Taken together, this study reveals the important role of this PKC beta-ERK(1/2)/p38MAPK-HSP27 pathway, which was verified for the first time, in modulating HCC cell motility and invasion.
|
18167130 |
2008 |
Liver carcinoma
|
0.400 |
PosttranslationalModification
|
disease |
BEFREE |
Our results strongly suggest that activation of PKCdelta regulates the phosphorylation of HSP27 via p38 MAPK in human HCC.
|
17673262 |
2007 |
Liver carcinoma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
|
16400691 |
2006 |
Liver carcinoma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Thus, 2-DE based serum proteome analysis can be useful in the screening of serum biomarkers for HCC and HSP27 could aid in the diagnosis of HCC though further validation is needed.
|
16240287 |
2005 |